Suppr超能文献

基因检测从靶向检测到基因组合检测,以及从患者导向检测到群体检测的演变:我们实现目标了吗?

The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?

作者信息

Gima Lauren, Solomon Ilana, Hampel Heather

机构信息

Division of Clinical Cancer Genomics, City of Hope National Medical Center, Duarte, California.

出版信息

Clin Colon Rectal Surg. 2023 Jul 19;37(3):133-139. doi: 10.1055/s-0043-1770381. eCollection 2024 May.

Abstract

The field of cancer genetics has evolved significantly over the past 30 years. Genetic testing has become less expensive and more comprehensive which has changed practice patterns. It is no longer necessary to restrict testing to those with the highest likelihood of testing positive. In addition, we have learned that the criteria developed to determine who has the highest likelihood of testing positive are neither sensitive nor specific. As a result, the field is moving from testing only the highest risk patients identified based on testing criteria to testing all cancer patients. This requires new service delivery models where testing can be mainstreamed into oncology clinics and posttest genetic counseling can be provided to individuals who test positive and those with concerning personal or family histories who test negative. The use of videos, testing kiosks, chatbots, and genetic counseling assistants have been employed to help facilitate testing at a larger scale and have good patient uptake and satisfaction. While testing is important for cancer patients as it may impact their treatment, future cancer risks, and family member's cancer risks, it is unfortunate that their cancer could not be prevented in the first place. Population testing for all adults would be a strategy to identify individuals with adult-onset diseases before they develop cancer in an attempt to prevent it entirely. A few research studies (Healthy Nevada and MyCode) have offered population testing for the three Centers for Disease Control and Prevention Tier 1 conditions: hereditary breast and ovarian cancer syndrome, Lynch syndrome, and familial hypercholesterolemia finding a prevalence of 1 in 70 individuals in the general population. We anticipate that testing for all cancer patients and the general population will continue to increase over the next 20 years and the genetics community needs to help lead the way to ensure this happens in a responsible manner.

摘要

在过去30年里,癌症遗传学领域有了显著发展。基因检测变得更便宜且更全面,这改变了医疗实践模式。不再需要将检测局限于检测呈阳性可能性最高的人群。此外,我们了解到,用于确定谁检测呈阳性可能性最高的标准既不敏感也不特异。因此,该领域正从仅对根据检测标准确定的最高风险患者进行检测,转向对所有癌症患者进行检测。这需要新的服务提供模式,使检测能够融入肿瘤诊所的主流,并为检测呈阳性的个体以及检测呈阴性但有相关个人或家族病史的个体提供检测后遗传咨询。视频、检测亭、聊天机器人和遗传咨询助手的使用,有助于在更大规模上推动检测,且患者接受度高、满意度好。虽然检测对癌症患者很重要,因为它可能影响其治疗、未来患癌风险以及家庭成员的患癌风险,但遗憾的是,他们的癌症从一开始就无法预防。对所有成年人进行群体检测将是一种策略,即在个体患成年发病疾病并发展为癌症之前识别他们,试图完全预防癌症。一些研究(内华达健康计划和我的基因计划)针对美国疾病控制与预防中心的三类一级疾病提供了群体检测:遗传性乳腺癌和卵巢癌综合征、林奇综合征和家族性高胆固醇血症,发现普通人群中患病率为七十分之一。我们预计,在未来20年里,对所有癌症患者和普通人群的检测将持续增加,遗传学领域需要引领方向,以确保这一过程以负责任的方式进行。

相似文献

1
The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?
Clin Colon Rectal Surg. 2023 Jul 19;37(3):133-139. doi: 10.1055/s-0043-1770381. eCollection 2024 May.
3
Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome.
Cancer Control. 2023 Jan-Dec;30:10732748231175011. doi: 10.1177/10732748231175011.
6
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
7
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
9
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Gastroenterology. 2015 Sep;149(3):604-13.e20. doi: 10.1053/j.gastro.2015.05.006. Epub 2015 May 14.
10
Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
Healthcare (Basel). 2016 Jan 27;4(1):14. doi: 10.3390/healthcare4010014.

引用本文的文献

1
Addressing family communication in genetic counseling: A scoping review of process studies.
J Genet Couns. 2025 Aug;34(4):e70067. doi: 10.1002/jgc4.70067.
2
Prospective changes in primary care patients' family communication after skin cancer genetic test offer.
PEC Innov. 2025 Jun 7;7:100409. doi: 10.1016/j.pecinn.2025.100409. eCollection 2025 Dec.

本文引用的文献

2
From the patient to the population: Use of genomics for population screening.
Front Genet. 2022 Oct 24;13:893832. doi: 10.3389/fgene.2022.893832. eCollection 2022.
3
Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
JAMA Netw Open. 2022 Sep 1;5(9):e2232787. doi: 10.1001/jamanetworkopen.2022.32787.
7
Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerations.
Gynecol Oncol. 2022 Sep;166(3):538-542. doi: 10.1016/j.ygyno.2022.07.016. Epub 2022 Jul 21.
8
Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for All GI Cancers?
J Clin Oncol. 2022 Aug 20;40(24):2681-2692. doi: 10.1200/JCO.21.02764. Epub 2022 Jun 1.
10
Health equity in the implementation of genomics and precision medicine: A public health imperative.
Genet Med. 2022 Aug;24(8):1630-1639. doi: 10.1016/j.gim.2022.04.009. Epub 2022 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验